Eventide Asset Management - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$15,159,000
-2.3%
724,972
-17.3%
0.20%
-3.8%
Q2 2021$15,513,000
+47.3%
876,948
+103.9%
0.21%
+33.3%
Q1 2021$10,535,000
-27.6%
430,0000.0%0.16%
-30.0%
Q4 2020$14,556,000430,0000.22%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Column Group LLC 4,768,181$84,349,00011.94%
Memorial Sloan Kettering Cancer Center 602,272$10,654,0006.96%
Euclidean Capital LLC 996,734$17,632,0005.72%
Invus Financial Advisors, LLC 1,007,575$17,824,0003.55%
EcoR1 Capital, LLC 3,092,218$54,701,0002.04%
Orbimed Advisors 2,337,574$41,352,0000.42%
EMERALD ADVISERS, LLC 602,758$10,663,0000.39%
EMERALD MUTUAL FUND ADVISERS TRUST 557,210$9,857,0000.32%
Casdin Capital, LLC 601,515$10,641,0000.27%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 53,000$938,0000.25%
View complete list of ORIC PHARMACEUTICALS INC shareholders